A look at IgA responses of COVID-19 patient sera to known human autoantigens.
Studies report a link between COVID-19 disease severity and autoimmunity, with growing evidence showing development of autoantibodies as a result of long-lasting or life threatening cases of SARS-CoV-2 infection. Discover the new PEPperCHIP® Autoimmune Human Epitope Microarray with 3,723 human B-cell epitopes associated with autoimmune diseases. The microarray enables you to:
- Monitor autoantibody development in COVID-19 patient sera.
- Identify autoantibody responses after COVID-19 infection
- Investigate autoantibody responses before and after COVID-19 vaccination.
- Correlate IgG or IgA autoantibodies with disease progression.
- Analyze autoantibody responses in animal models on the epitope level.